Clinical trials
Terminated Phase 2 Triple Negative Breast Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
52 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2010 | 5 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 3 |
| 2016 | 2 |
| 2017 | 10 |
| 2018 | 3 |
| 2019 | 4 |
| 2020 | 6 |
| 2021 | 10 |
| 2022 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 52 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sun Yat-sen University | 3 |
| University of Wisconsin, Madison | 3 |
| G1 Therapeutics, Inc. | 2 |
| M.D. Anderson Cancer Center | 2 |
| National Cancer Institute (NCI) | 2 |
| AVEO Pharmaceuticals, Inc. | 1 |
| Ayala Pharmaceuticals, Inc, | 1 |
| Barbara Ann Karmanos Cancer Institute | 1 |
| BerGenBio ASA | 1 |
| Bryan Schneider, MD | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Triple Negative Breast Neoplasms | 52 |
| Breast Neoplasms | 28 |
| Neoplasm Metastasis | 4 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Breast Neoplasms, Male | 2 |
| Carcinoma, Renal Cell | 2 |
| Inflammatory Breast Neoplasms | 2 |
| Melanoma | 2 |
| Pancreatic Neoplasms | 2 |
| Basal Cell Carcinoma | 1 |
Trials
Showing 1 to 25 of 52. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.